Literature DB >> 21094591

Performance contracting to engage detoxification-only patients into continued rehabilitation.

Sean J Haley1, Karen Leggett Dugosh, Kevin G Lynch.   

Abstract

In 2006, only 18.7% of Delaware's detoxification patients were admitted to continuing recovery-oriented treatment within 30 days after discharge. In response, Delaware established financial contingencies to (1) maintain 90% detoxification occupancy, (2) make receipt of 10% of the facility's monthly reimbursement contingent on 25% of patients entering treatment, and (3) provide a $500 bonus for every patient with three or more prior detoxification visits who was retained in treatment. Under the performance contract, the detoxification provider (1) maintained the 90% occupancy requirement, (2) achieved the 25% treatment entry target for 7 of 12 months, and (3) observed only 8% (27/337) of detoxification completions that met the targeted length of stay. Continuation to and retention in treatment was even more constrained for patients with three or more prior detoxifications. Contrary to the policy intent, the number of patients with three or more detoxifications in fiscal year (FY) 2008 is nearly triple that of FY 2006. The modest gain in the transition rate was achieved without changes in patient access; the FY 2008 patient population reported significantly higher rates of homelessness and a younger age of first use than before the performance contract in FY 2006. Performance contracting may offer promise for improving transition to treatment rates. However, the unique needs of detoxification patients, the treatment capacity of each level of care to meet patient needs, and the structure of the performance contract must be carefully considered. Performance contracting efforts may be strengthened when service contracts across the system are tightly synchronized.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21094591     DOI: 10.1016/j.jsat.2010.09.001

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

1.  Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification.

Authors:  Andrea Acevedo; Margaret T Lee; Deborah W Garnick; Constance M Horgan; Grant A Ritter; Lee Panas; Kevin Campbell; Jason Bean-Mortinson
Journal:  Drug Alcohol Depend       Date:  2017-12-16       Impact factor: 4.492

Review 2.  Can We Pay for Performance in Behavioral Health Care?

Authors:  Rebecca E Stewart; Ishara Lareef; Trevor R Hadley; David S Mandell
Journal:  Psychiatr Serv       Date:  2016-12-01       Impact factor: 3.084

3.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

4.  Incentives in a public addiction treatment system: Effects on waiting time and selection.

Authors:  Maureen T Stewart; Sharon Reif; Beth Dana; AnMarie Nguyen; Maria Torres; Margot T Davis; Grant Ritter; Dominic Hodgkin; Constance M Horgan
Journal:  J Subst Abuse Treat       Date:  2018-09-07

5.  Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Authors:  Michael D Stein; Bradley J Anderson; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2015-07-14

6.  Essential Ingredients for Successful Redesign of Addiction Treatment.

Authors:  David H Gustafson
Journal:  Bridge (Kans City)       Date:  2012

Review 7.  Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes?

Authors:  Dominic Hodgkin; Deborah W Garnick; Constance M Horgan; Alisa B Busch; Maureen T Stewart; Sharon Reif
Journal:  Drug Alcohol Depend       Date:  2019-11-14       Impact factor: 4.492

8.  Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State.

Authors:  Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Margaret T Lee; Lee Panas; Grant A Ritter; Kevin Campbell; Jason Bean-Mortinson
Journal:  J Subst Abuse Treat       Date:  2017-09-14

9.  Effectiveness of value-based purchasing for substance use treatment engagement and retention.

Authors:  Sharon Reif; Maureen T Stewart; Maria E Torres; Margot T Davis; Beth Mohr Dana; Grant A Ritter
Journal:  J Subst Abuse Treat       Date:  2020-12-03

10.  Association of Alternative Payment and Delivery Models With Outcomes for Mental Health and Substance Use Disorders: A Systematic Review.

Authors:  Andrew D Carlo; Nicole M Benson; Frances Chu; Alisa B Busch
Journal:  JAMA Netw Open       Date:  2020-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.